Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden

Similar documents
Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Authentication Solution for Currency Management

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

2019 Application Form

Creata Business Ventures Limited. Investment Opportunities

RAISING PRIVATE FINANCE IN THE WATER SECTOR: TRENDS & EXAMPLES. Helping SME s bring ideas to market Fiona Griffith 11 October 2016

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

IP and Technology Management for Universities

Opportunities and Innovation in ICT / Emerging trends & industries

Chapter 5. Forms of Business Ownership and Organization

University IP and Technology Management. University IP and Technology Management

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Commercialization Strategies that Work

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CDP-EIF ITAtech Equity Platform

Working with SMEs on projects

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

MONTHLY REPORT JUNE 2018 XTPL S.A. Wrocław, r.

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Moving from Nano-Ideas to Nanomanufacturing. Alan Rae February 2008

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants

Private Equity Market and Trends Brigitte Baumann CEO Go Beyond; President of EBAN

Contents. 1 Introduction... 1

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities

University Technology Transfer, Innovation Ecosystem and EIE Project

Intellectual Property Management - How to capture, protect and exploit your ideas

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BUILDING DIGITAL SKILLS A DIGITAL EUROPE NEEDS DIGITAL SKILLS

Het belang van IP voor Venture Capital Backed bedrijven

Technology Leadership Course Descriptions

The Intellectual Property, Knowledge Transfer: Perspectives

What is InnovFin Equity?

The role of university science parks in business-university research collaboration

COLLABORATIVE R&D & IP ISSUES IN TECHNOLOGY TRANSFER IN UNIVERSITY SYSTEM

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cherry AB. The most complete gaming company Partnering with entrepreneurs to explore exciting ideas

Digital Identity. Workshop. Roland Berger Munich Office

Robert A. Greising Partner

OECD s Innovation Strategy: Key Findings and Policy Messages

Asking Questions on Knowledge Exchange and Exploitation in the Business R&D and Innovation Survey

Fujitsu Laboratories R&D Strategy. April 4, 2008 Kazuo Murano, Ph.D. President Fujitsu Laboratories Ltd.

Laser Surface Authentication TM : biometrics for documents and goods

Globalisation increasingly affects how companies in OECD countries

EU-India collaboration in the SME sector Turning environmental challenges into opportunities. 22 July 2010, New Delhi

Facilitating Technology Transfer and Management of IP Assets:

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Financing Emerging Growth Companies

Country Profile: Israel

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

Dr Angela Maxwell OBE. Curriculum Vitae

British Business Bank

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

At the forefront of Abu Dhabi s economic diversification. August 2008

Regional innovation strategies: the Apulian experience and the role of ARTI, the Regional Agency for Technology and Innovation

Venture Capital Search Highlights

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure

Prof. Laura Lechuga Prof. Ángel Maquieira Prof. Rosa Puchades Dra. Maria J. Bañuls

COMMERCIAL INDUSTRY RESEARCH AND DEVELOPMENT BEST PRACTICES Richard Van Atta

OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS

Change the Game, SMEs! Leverage on your IP

Robert A. Greising Partner

Getting Started. This Lecture

Intellectual Property and the Commercialisation Process. An Overview

Industrial Partnerships and Technology Transfer. Celine Serrano Transfer and Innovation Department

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

IN-DEPTH ASSESSMENT OF THE SITUATION (CONTRACT NO ENTR/2010/16, LOT 2) Task 6: Research, Development and Innovation in the Footwear Sector

SMEs and European Programmes: opportunity or fatal attraction? Marco d Angelantonio CEO - HIM SA

Technology Transfer at CERN

From FP7 towards Horizon 2020 Workshop on " Research performance measurement and the impact of innovation in Europe" IPERF, Luxembourg, 31/10/2013

The business of Intellectual Property

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Activities on Business, Academia and Government collaboration Fund in Tohoku Region, (Tohoku Incubation Fund)

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Speed Innovation Happiness. Corporate Overview

Investing in Regional Sustainability Norris Lozano, PDC

Accelerating Collective Innovation: Investing in the Innovation Landscape

IDEO PROJECT. Venture Capital & Private Equity LATVIA

Technology transfer and development: implications of four case studies Session 2

2018 1Q IR PRESENTATION

Horizon 2020 and Photonics

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Top 50 Emerging Technologies & Growth Opportunities

2010/IPEG/SYM/003 Measures for Encouraging Patent Licensing - INPIT Challenges

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SMEC BUDGET 2017 RECOMMENDATIONS PRESS CONFERENCE 4 JANUARY 2017, WEDNESDAY. Opening Address by Mr Lawrence Leow, Chairman of SMEC

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Embracing Open Title Innovation Platforms

Career Pathways Talk - 28 July 2016 (Thursday) 2015 ISCA

Presentation. March 2007

Notes from a seminar on "Tackling Public Sector Fraud" presented jointly by the UK NAO and H M Treasury in London, England in February 1998.

SMEs. Access to finance for. Screening Process with Serbia - Chapter 20. SME Access to Finance Directorate-General for Enterprise and Industry

IEEE Boston Entrepreneurs Network. Raising Money from VCs. April 2012

IM - Innovation Management

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NEW YORK UNIVERSITY Stern School of Business

Transcription:

2010 Bilcare Technologies. Privileged presentation, slide 1 Singular ID The Story of Commercialising a Materials Technology in Singapore Adrian Burden Co-founding Director of Singular ID President Europe of Bilcare Technologies

2010 Bilcare Technologies. Privileged presentation, slide 2 Overview My background Phase 1 R&D Materials R&D project and applications Proof-of-principle Business Planning Phase 2 spinning-off Venture capital finance & operations First customer & manufacturing partners Phase 3 - growth Overseas expansion, new applications Product launch, further financing Phase 4 exit Acquisition New opportunities and future prospects 2002 2003 2004 2005 2006 2007 2008 2009

2010 Bilcare Technologies. Privileged presentation, slide 3 My background MA Cantab, University of Cambridge Natural Sciences (materials) D.Phil. Oxon, University of Oxford Department of materials, electron microscopy of carbon Founding President of the OU lifesaving club Raychem Ltd, UK Corporate R&D, conductive polymer composites University of Surrey, UK Post doctoral research amorphous carbon films Printable Field Emitters Ltd, UK R&D Manager field emission display technology Institute of Materials Research & Engineering (IMRE) Senior Scientist and Business Development Manager OLED technology, ON-Singapore & Technology Roadmapping Singular ID Pte Ltd Founding CEO Bilcare Technologies President, Europe

2010 Bilcare Technologies. Privileged presentation, slide 4 Phase 1 R&D

2010 Bilcare Technologies. Privileged presentation, slide 5 Phase 1 the R&D project Singapore 2003 2004 2005 2006 2007 2008 R&D Project IMRE / A-STAR

2010 Bilcare Technologies. Privileged presentation, slide 6 Phase 1 the R&D project Magnetic hard disk drive technology Quest for ever-denser information storage In-plane to out-of-plane magnetic bits Materials R&D nanotechnology of candidate films Highly regular and uniform disk media very difficult! Image source: Hitachi Global Storage Technologies

2010 Bilcare Technologies. Privileged presentation, slide 7 Phase 1 the passport analogy Passport number Serial # or index # Makes searching a database quick and easy Photograph, signature or fingerprint The security / biometric Giving products fingerprints Materials fingerprint The security feature Cannot be replicated Barcode Serial # or index # Makes searching a database quick and easy

2010 Bilcare Technologies. Privileged presentation, slide 8 Phase 1 applications: the problem of counterfeits Authorised distribution Grey market diversion Impact on Brand Owner Lower margins Unforeseen liabilities Distribution license issues Brand owner R&D $ Quality Testing Authorised factory Product overruns Lost revenues Over supply Increased warranty claims Lower margins Counterfeit products Lost revenues Increased warranty claims Brand erosion Product liabilities Copycat factory Interpol estimates 5-7% of world trade involves counterfeits This is equivalent to over USD 500 billion in lost sales

2010 Bilcare Technologies. Privileged presentation, slide 9 Phase 1 leading to a proof-of-principle Credit cards and paper with fingerprint tag Scanner with sensor and electronics Mobile phone and software Back-end database

2010 Bilcare Technologies. Privileged presentation, slide 10 Phase 1 R&D - Highlights Proof of Principle Publicity Singular ID Market Research Business Plan License Agreement Explaining the technology to the President of Singapore Signing of the license agreement

2010 Bilcare Technologies. Privileged presentation, slide 11 Phase 1 - our toolbox Laboratory log books Travellers / process control TRAV 1.1, 2.1, etc First-cut roadmap Non-Disclosure Agreements Executive Summary EXEC 1.1, 1.2, etc Business Plan Information sheets Presentation License Agreement (and benchmarks)

2010 Bilcare Technologies. Privileged presentation, slide 12 Phase 1 - our first-cut roadmap Mid 2005 Spin-off 2006 2007 2008 Market trends Finance & Revenue Infrastructure Accreditation Staff Revenue Materials Tag Scanner Dispenser Database

2010 Bilcare Technologies. Privileged presentation, slide 13 Phase 1 looking back What we did well Kept detailed records of all work and correspondence Created an internal shared IT resource Used government funding to create a proof-of-principle Filed 2 patents that became a good foundation Negotiated a fair / rigorous license agreement Started some early branding & publicity Where we could have done better Secured venture finance before spinning-off Found a customer before spinning-off Had a more relevant hand-held prototype device

2010 Bilcare Technologies. Privileged presentation, slide 14 Phase 2 Spinning Off

2010 Bilcare Technologies. Privileged presentation, slide 15 Phase 2 spinning-off & starting operations Singapore 2003 2004 2005 2006 2007 2008 R&D Project IMRE / A-STAR Spin-off company 1 st runner-up finalist winner Series A Acquired by Bilcare

2010 Bilcare Technologies. Privileged presentation, slide 16 Phase 2 - why Singapore? Universities & Research Institutes Incubators & Science Parks National infrastructure & capability Basic research Platform technology Prototypes Business development Supply chain integration Scale-up & manufacturing Application driven Sales Overseas Marketing & growth R&D Start-up IT & IP generation Logistics equipment community infrastructure Business Corporate Education R&D grants acumen governance

2010 Bilcare Technologies. Privileged presentation, slide 17 Phase 2 why Singapore? R&D Science, Engineering, Biomedical Applied research and enhancement schemes Economic development Attracting MNCs, supporting SMEs Standards and Productivity Supports technology and commerce International Enterprise Overseas expansion and branding Infocomm Development IT and infrastructure focused Other agencies and organisations play important roles too

2010 Bilcare Technologies. Privileged presentation, slide 18 Phase 2 Spinning off - Highlights Investment from Advance Nanotech Winner of Major Business Plan Competition Production Partners Product Development

2010 Bilcare Technologies. Privileged presentation, slide 19 Phase 2 our operational model Leveraging on alliances Channel Marketing Joint ventures Brand security companies IT Platform companies Customers Singular ID IP & Systems Integration Out-sourcing & partnerships Established hardware suppliers Scanner contract manufacturers Tag and Label contract manufacturers Data management Internet & Mobile service providers

2010 Bilcare Technologies. Privileged presentation, slide 20 Phase 2 lucky break

2010 Bilcare Technologies. Privileged presentation, slide 21 Phase 2 our toolbox Company templates NDAs, Travellers, etc Employment contracts Accounting package (Excel to start!) Term sheets / Investment Agreements Letter Agreements PO system, Invoice system, CRM Budget sheets Board Reports Server

2010 Bilcare Technologies. Privileged presentation, slide 22 Phase 2 looking back What we did well Moved into presentable incubation premises Generated publicity Secured venture finance Obtained a customer and had focus Watched the cash flow carefully Secured a government R&D grant Won a significant business plan competition Where we could have done better Secured a bit more finance Captured more of the lower end of the market Added a more senior member to our team earlier on Used a good accounting package early on

2010 Bilcare Technologies. Privileged presentation, slide 23 Phase 3 Growth

2010 Bilcare Technologies. Privileged presentation, slide 24 Phase 3 growth Padua, Italy Singapore 2003 2004 2005 2006 2007 2008 R&D Project IMRE / A-STAR Spin-off company winner 1 st runner-up finalist winner Series A Acquired by Bilcare

2010 Bilcare Technologies. Privileged presentation, slide 25 Phase 3 - our first customer Sanden, air-conditioning compressor Sanden Non-Sanden

2010 Bilcare Technologies. Privileged presentation, slide 26 Phase 3 Sanden s production line

2010 Bilcare Technologies. Privileged presentation, slide 27 Phase 3 - fashion & luxury sector Partnership with Euromark to make enxure labels for the European luxury goods segment Euromark overview holds about 30% market share of labels for European handbags and clothing Current status Identified European launch customer Labels passed all customer s testing to date

2010 Bilcare Technologies. Privileged presentation, slide 28 Phase 3 - no to fakes Visit www.notofakes.com for more information about fake products As a brand owner you can connect with customers using our hosted page service

2010 Bilcare Technologies. Privileged presentation, slide 29 Phase 3 Growth - Highlights Minister of State for Trade & Industry, Singapore, attended product launch Awards New Investors Launch Customer

2010 Bilcare Technologies. Privileged presentation, slide 30 Phase 3 our toolbox Accounting package (MYOB) More term sheets / Investment Agreements Detailed due diligence directories Extensive warrants and disclosures Product literature & user manuals EULAs and other Terms & Conditions Patents, trademarks, domain names management Publicity archive Permanent exhibits

2010 Bilcare Technologies. Privileged presentation, slide 31 Phase 3 looking back What we did well Continued to keep the information flowing Had serious acquisition discussions Used students to keep the cost down Launched a product Continued to watch the cash flow Secured another government R&D grant Where we could have done better Been less distracted by range of commercial opportunities Raised money overseas more quickly Organised our IT system ahead of future staff expansion

2010 Bilcare Technologies. Privileged presentation, slide 32 Phase 4 Exit and the future

2010 Bilcare Technologies. Privileged presentation, slide 33 Phase 4 Exit and the future 2003 2004 2005 2006 2007 2008 R&D Project IMRE / A-STAR Spin-off company Bilcare company winner 1 st runner-up finalist winner Series A Acquired by Bilcare

2010 Bilcare Technologies. Privileged presentation, slide 34 Phase 4 - Bilcare

2010 Bilcare Technologies. Privileged presentation, slide 35 Phase 4 Highlights Rebranding and new marketing material New range of products The nonclonable TM system More awards

2010 Bilcare Technologies. Privileged presentation, slide 36 Phase 4 - the future Bluetooth nonclonable reader Scan then touch Phone, PDA, laptop, PC Results via GPRS / internet nonclonable label DataMatrix & fingerprint combined

2010 Bilcare Technologies. Privileged presentation, slide 37 Overall - looking back Positive Our technology is defect tolerant Singapore was an excellent place to start a business We had a clear vision and stayed focused We learnt a huge amount in a short space of time We kept the news flowing Negative Raising early stage funding for high technology was extremely difficult There are lots of balls in the air when you run a technology start-up. You need to quickly learn to juggle!